oa Southern African Journal of Epidemiology and Infection - The emergence of carbapenem resistance in in South Africa : editorial



The high levels of extended-spectrum β-lactamase (ESBL) in South Africa, especially documented for , in both the public sector (55-74%), as reported by Bamford et al in this edition of the SAJEI, and in the private sector (55-60%) shown previously, is disconcerting. Carbapenems are the cornerstone of therapy for patients with serious infections caused by ESBL-producing organisms.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error